BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Pancreatic cancer AND HRAS, K-ras, 3265, ENSG00000174775, HRAS1, RASH1, c-bas/has, P01112, N-ras AND Prognosis
107 results:

  • 1. Synergistic effect of antagonists to KRas4B/PDE6 molecular complex in pancreatic cancer.
    Briseño-Díaz P; Schnoor M; Bello-Ramirez M; Correa-Basurto J; Rojo-Domínguez A; Arregui L; Vega L; Núñez-González E; Palau-Hernández LA; Parra-Torres CG; García Córdova OM; Zepeda-Castilla E; Torices-Escalante E; Domínguez-Camacho L; Xoconostle-Cazares B; Meraz-Ríos MA; Delfín-Azuara S; Carrión-Estrada DA; Villegas-Sepúlveda N; Hernández-Rivas R; Thompson-Bonilla MDR; Vargas M
    Life Sci Alliance; 2023 Dec; 6(12):. PubMed ID: 37813486
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Small molecular inhibitors for KRAS-mutant cancers.
    Wu X; Song W; Cheng C; Liu Z; Li X; Cui Y; Gao Y; Li D
    Front Immunol; 2023; 14():1223433. PubMed ID: 37662925
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. A comprehensive review of pancreatic cancer and its therapeutic challenges.
    Jiang S; Fagman JB; Ma Y; Liu J; Vihav C; Engstrom C; Liu B; Chen C
    Aging (Albany NY); 2022 Sep; 14(18):7635-7649. PubMed ID: 36173644
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Bcl-2 and Noxa are potential prognostic indicators for patients with gastroenteropancreatic neuroendocrine neoplasms.
    Guo Y; Zhang L; Zhang N; Chen L; Luo Q; Liu M; Yang D; Chen J
    Endocrine; 2022 Oct; 78(1):159-168. PubMed ID: 35895181
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Recent Advances in pancreatic cancer: Novel Prognostic Biomarkers and Targeted Therapy-A Review of the Literature.
    Schlick K; Kiem D; Greil R
    Biomolecules; 2021 Oct; 11(10):. PubMed ID: 34680101
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Role of primary cilium in pancreatic ductal adenocarcinoma (Review).
    Sabanovic B; Giulietti M; Piva F
    Int J Oncol; 2020 Nov; 57(5):1095-1102. PubMed ID: 33491761
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Prognostic value of circulating tumor DNA in pancreatic cancer: a systematic review and meta-analysis.
    Fang Z; Meng Q; Zhang B; Shi S; Liu J; Liang C; Hua J; Yu X; Xu J; Wang W
    Aging (Albany NY); 2020 Dec; 13(2):2031-2048. PubMed ID: 33318293
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. CXCR3 and Cognate Ligands are Associated with Immune Cell Alteration and Aggressiveness of pancreatic Ductal Adenocarcinoma.
    Cannon A; Thompson CM; Maurer HC; Atri P; Bhatia R; West S; Ghersi D; Olive KP; Kumar S; Batra SK
    Clin Cancer Res; 2020 Nov; 26(22):6051-6063. PubMed ID: 32873571
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Cold Shock Domain Containing E1 (CSDE1) Protein is Overexpressed and Can be Targeted to Inhibit Invasiveness in pancreatic cancer Cells.
    Liu H; Li X; Dun MD; Faulkner S; Jiang CC; Hondermarck H
    Proteomics; 2020 May; 20(10):e1900331. PubMed ID: 32170829
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Rce1 suppresses invasion and metastasis of hepatocellular carcinoma via epithelial-mesenchymal transition induced by the TGF-β1/H-Ras signaling pathway.
    Ma C; Yang Y; Xu L; Tu W; Chen F; Wang J
    J Cell Physiol; 2020 Mar; 235(3):2506-2520. PubMed ID: 31506952
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Fendiline Enhances the Cytotoxic Effects of Therapeutic Agents on PDAC Cells by Inhibiting Tumor-Promoting Signaling Events: A Potential Strategy to Combat PDAC.
    Alhothali M; Mathew M; Iyer G; Lawrence HR; Yang S; Chellappan S; Padmanabhan J
    Int J Mol Sci; 2019 May; 20(10):. PubMed ID: 31100813
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. GNAS but Not Extended RAS Mutations Spectrum are Associated with a Better prognosis in Intraductal pancreatic Mucinous Neoplasms.
    Gaujoux S; Parvanescu A; Cesaretti M; Silve C; Bieche I; Rebours V; Lévy P; Sauvanet A; Cros J
    Ann Surg Oncol; 2019 Aug; 26(8):2640-2650. PubMed ID: 31025231
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Ras-ERK1/2 signalling promotes the development of osteosarcoma through regulation of H4K12ac through HAT1.
    Zhang J; Liu M; Liu W; Wang W
    Artif Cells Nanomed Biotechnol; 2019 Dec; 47(1):1207-1215. PubMed ID: 30942624
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Dietary Garcinol Arrests pancreatic cancer in p53 and k-ras Conditional Mutant Mouse Model.
    Saadat N; Akhtar S; Goja A; Razalli NH; Geamanu A; David D; Shen Y; Gupta SV
    Nutr Cancer; 2018 Oct; 70(7):1075-1087. PubMed ID: 30273070
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Chronologic changes in clinical and survival features of pancreatic ductal adenocarcinoma since 2000: A single-center experience with 2,029 patients.
    Shin SH; Kim SC; Song KB; Hwang DW; Lee JH; Park KM; Lee YJ
    Surgery; 2018 Sep; 164(3):432-442. PubMed ID: 29884479
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. MicroRNA regulation of k-ras in pancreatic cancer and opportunities for therapeutic intervention.
    Karmakar S; Kaushik G; Nimmakayala R; Rachagani S; Ponnusamy MP; Batra SK
    Semin Cancer Biol; 2019 Feb; 54():63-71. PubMed ID: 29199014
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. pancreatic cancer Stem Cells and Therapeutic Approaches.
    Ercan G; Karlitepe A; Ozpolat B
    Anticancer Res; 2017 Jun; 37(6):2761-2775. PubMed ID: 28551612
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Familial pancreatic cancer: Concept, management and issues.
    Matsubayashi H; Takaori K; Morizane C; Maguchi H; Mizuma M; Takahashi H; Wada K; Hosoi H; Yachida S; Suzuki M; Usui R; Furukawa T; Furuse J; Sato T; Ueno M; Kiyozumi Y; Hijioka S; Mizuno N; Terashima T; Mizumoto M; Kodama Y; Torishima M; Kawaguchi T; Ashida R; Kitano M; Hanada K; Furukawa M; Kawabe K; Majima Y; Shimosegawa T
    World J Gastroenterol; 2017 Feb; 23(6):935-948. PubMed ID: 28246467
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Analysis of ctDNA to predict prognosis and monitor treatment responses in metastatic pancreatic cancer patients.
    Cheng H; Liu C; Jiang J; Luo G; Lu Y; Jin K; Guo M; Zhang Z; Xu J; Liu L; Ni Q; Yu X
    Int J Cancer; 2017 May; 140(10):2344-2350. PubMed ID: 28205231
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. k-ras mutation detection in liquid biopsy and tumor tissue as prognostic biomarker in patients with pancreatic cancer: a systematic review with meta-analysis.
    Li T; Zheng Y; Sun H; Zhuang R; Liu J; Liu T; Cai W
    Med Oncol; 2016 Jul; 33(7):61. PubMed ID: 27225938
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 6.